Stronger Sell Today ACOR ranks #5182 as SELL CANDIDATE #5182 Weaker Sell

ACOR stock forecast Acorda Therapeutics

ACOR stock forecast





ACOR Forecast and Technical Stock Analysis

Sell candidate since 2019-05-07 Loss -40.67%

Acorda Therapeutics gained 0.15% in the last trading day ( Friday, 19th Jul 2019 ), rising from $6.89 to $6.90 During day the stock fluctuated 2.49% from a day low at $6.83 to a day high of $7.00. The price has fallen in 6 of the last 10 days and is down by -6.25% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 57 764 more shares were traded than the day before. In total, 606 758 shares bought and sold for approximately $4.19 million.

Quick summary:

  • 30 day high of the ACOR stock price was $8.08 and low was $6.40.
  • 90 day high was $12.15 and low was $6.40.
  • 52 week high for the Acorda Therapeutics - $29.75 and low - $6.40.
Top Trending Stocks


Acorda Therapeutics lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $7.44 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -43.68% during the next 3 months and, with 90% probability hold a price between $2.64 and $4.19 at the end of this period.

Top Golden Star Stocks


Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Acorda Therapeutics holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $7.51. On a fall, the stock will find some support from the short-term average at $6.82. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Wednesday July 17, 2019, which indicates further falls until a new bottom pivot has been found.

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 31 and the stock is currently not being overbought or oversold

* uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Support & Resistance

Acorda Therapeutics finds support from accumulated volume at $6.88.

Support: $6.88 Price: $6.90 Resistance: $7.11


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.17 between high and low, or 2.49%. For the last week, the stock has had a daily average volatility of 4.12%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

4.12 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Sell Candidate Downgraded


Acorda Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today ACOR ranks #5182 as SELL CANDIDATE #5182 Weaker Sell

Will ACOR stock price go up or down on Mon, 22 Jul 2019?

Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at